Approved Drug Products with Therapeutic Equivalence Evaluation
Executive Summary
The sixth edition of the FDA publication now contains patent information, NDA numbers, approval dates, exclusivity information, and therapeutic equivalence evaluations for multiple source drug products. List is available from the Superintendent of Documents, U.S. Govt. Printing Office, Washington, D.C. 20402 and should be requested by name. Subscription fee is $103 ($128.75 for foreign subscriptions), which also covers monthly cumulative supplements.